Lantern Pharma Announces Public Release of AI Module for Blood-Brain Barrier Permeability Prediction

Lantern Pharma has released an AI module, predictBBB.ai, which predicts blood-brain barrier permeability with 94% accuracy. This addresses a long-standing challenge in pharmaceutical development and establishes new benchmarks for computational drug discovery platforms. The technology leverages billions of molecular feature data points and real-time ensemble algorithm processing. The market for BBB technologies is projected to expand to $9.85 billion by 2032, making Lantern's solution a critical advancement in the field.